CD80 and myelodysplastic syndrome: Compared with high-risk MDS-MSC, low-risk MDS-MSC had little effect on CD1a, CD14, CD80 and CD86 expression (Figure 1A–B), indicating that the suppressive function of low-risk MDS-MSC on DCs differentiation was less than that of high-risk MDS-MSC.